Irritable Bowel Syndrome

Irritable Bowel Syndrome

woman at doctor holding stomach

The results of clinical trials that examined the efficacy of Trulance for patients with irritable bowel syndrome with constipation were recently presented at DDW 2017.

man in hospital bed

Participation in value-based care models helped reduce costs and improve outcomes related to inflammatory bowel diseases (IBD) treatment.

while pills

The FDA has discovered that a twice-daily medication to treat irritable bowel syndrome with diarrhea may have life-threatening effects on patients without a gallbladder.

Mayo Clinic researchers have found that patients suffering from pain related to irritable bowel syndrome may benefit from taking pregabalin, a neuro-pain inhibitor commonly used to treat fibromyalgia.

On Wednesday, the FDA approved two drugs to treat irritable bowel syndrome.

U.S. health regulators approved new irritable bowel syndrome drugs from Actavis Plc and Valeant Pharmaceuticals International Inc.

Ardelyx Inc said its experimental drug to treat constipation-related irritable bowel syndrome achieved the main goal of increasing bowel movements.

Irritable bowel syndrome (IBS), is a disorder associated with abdominal pain and discomfort and an altered bowel habit.

Salix Pharmaceuticals Ltd said its antibiotic rifaximin (Xifaxan) was safe and effective in a late-stage trial in treating patients with irritable bowel syndrome.

Ondansetron relieved some of the most annoying symptoms of irritable bowel syndrome with diarrhea (IBS-D).